Sp475

AGA LIVING GUIDELINES: MANAGEMENT OF MODERATE TO SEVERE ULCERATIVE COLITIS Q&A

Date
May 19, 2024

Presenters

Speaker Image for Edward Loftus
Mayo Foundation for Medical Education and Research
Speaker Image for Berkeley Limketkai
University of California Los Angeles

Tracks

Related Products

Thumbnail for PREVALENCE AND IMPACT OF PROTEIN-CALORIE MALNUTRITION IN PATIENTS HOSPITALIZED WITH GASTROINTESTINAL DISORDERS
PREVALENCE AND IMPACT OF PROTEIN-CALORIE MALNUTRITION IN PATIENTS HOSPITALIZED WITH GASTROINTESTINAL DISORDERS
This session would provide attendees with a foundational understanding of the pathophysiology of intestinal failure and short bowel syndrome which inform the management of the disease…
Thumbnail for RISANKIZUMAB MAINTENANCE THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: EFFICACY AND SAFETY IN THE RANDOMIZED PHASE 3 COMMAND STUDY
RISANKIZUMAB MAINTENANCE THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: EFFICACY AND SAFETY IN THE RANDOMIZED PHASE 3 COMMAND STUDY
BACKGROUND: Risankizumab (RZB), a monoclonal antibody targeting interleukin-23 p19, was evaluated for maintenance therapy in patients with moderately to severely active ulcerative colitis (UC) and clinical response to RZB intravenous (IV) induction treatment in a phase 3 double-blind, placebo (PBO)…
Thumbnail for Tadataka “Tachi” Yamada, MD, Lecture: Food as Medicine: How to Utilize Diet and Enhance Nutrition to Improve Outcomes in Foregut Diseases
Tadataka “Tachi” Yamada, MD, Lecture: Food as Medicine: How to Utilize Diet and Enhance Nutrition to Improve Outcomes in Foregut Diseases
LIVE STREAM SESSION This session will review evidence-based dietary approaches to management of patients with common foregut diseases including gastroesophageal reflux disease, eosinophilic esophagitis, and motility disorders of the esophagus and stomach…
Thumbnail for Novel Observations in IBD
Novel Observations in IBD
MONITORING IBD BY INTESTINAL ULTRASOUND DECREASES TIME TO TREATMENT CHANGE AND TIME TO REMISSION IN COMPARISON TO CONVENTIONAL MANAGEMENT: ANALYSIS OF PATIENTS WITH IBD ON MULTIPLE IBD THERAPIES